Silgan (SLGN)

Search documents
Silgan (SLGN) - 2024 Q1 - Earnings Call Transcript
2024-05-01 18:42
Silgan Holdings Inc. (NYSE:SLGN) Q1 2024 Earnings Conference Call May 1, 2024 11:00 AM ET Company Participants Alex Hutter - Vice President, Investor Relations Adam Greenlee - President and CEO Bob Lewis - Executive Vice President, Corporate Development and Administration Kim Ulmer - Senior Vice President and CFO Conference Call Participants Ghansham Panjabi - Baird Gabe Hadje - Wells Fargo Securities George Staphos - Bank of America Daniel Rizzo - Jefferies Matt Roberts - Raymond James Mike Roxland - Truis ...
Silgan (SLGN) - 2023 Q4 - Annual Report
2024-02-29 17:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-41459 SILGAN HOLDINGS INC. (Exact name of Registrant as specified in its charter) (State or other jurisdiction of incorporation or orga ...
Silgan (SLGN) - 2023 Q4 - Earnings Call Transcript
2024-01-31 21:28
Silgan Holdings Inc (NYSE:SLGN) Q4 2023 Earnings Call Transcript January 31, 2024 11:00 AM ET Company Participants Alex Hutter - Vice President of Investor Relations Adam Greenlee - President & CEO Kim Ulmer - CFO, Senior VP of Finance & Treasurer Robert Lewis - Executive VP, Corporate Development and Administration & Director Conference Call Participants George Staphos - Bank of America Matt Roberts - Raymond James Gabe Hadje - Wells Fargo Ghansham Panjabi - Baird Anthony Pettinari - Citi Mike Roxland - Tr ...
Silgan (SLGN) - 2023 Q3 - Quarterly Report
2023-11-02 14:54
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission file number 001-41459 SILGAN HOLDINGS INC. (Exact name of Registrant as specified in its charter) Delaware ...
Silgan (SLGN) - 2023 Q3 - Earnings Call Transcript
2023-10-25 17:00
Silgan Holdings Inc. (NYSE:SLGN) Q3 2023 Earnings Conference Call October 25, 2023 11:00 AM ET Company Participants Alex Hutter - Vice President, Investor Relations Adam Greenlee - President & Chief Executive Officer Kim Ulmer - Senior Vice President, Chief Financial Officer & Treasurer Bob Lewis - Executive Vice President, Corporate Development & Administration Conference Call Participants Ghansham Panjabi - Baird George Staphos - Bank of America Anthony Pettinari - Citi Gabe Hajde - Wells Fargo Matt Rober ...
Silgan (SLGN) - 2023 Q2 - Quarterly Report
2023-08-03 17:56
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission file number 001-41459 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) SILGAN HOLDINGS INC. (Exact name of Registrant as specified in its charter) Delaware 06-1 ...
Silgan (SLGN) - 2023 Q2 - Earnings Call Transcript
2023-07-26 20:05
Financial Data and Key Metrics Changes - Total adjusted EBIT for Q2 2023 was $160.8 million, a decrease of 14% year-over-year, with record adjusted EBIT in the Metal Containers segment offset by lower adjusted EBIT in the Dispensing & Specialty Closures and Custom Containers segments [27][55] - Adjusted net income per diluted share declined by $0.26 from the record achieved in Q2 2022, impacted by higher interest expense of $0.08 and non-recurring sales associated with Russia of $0.06 [27][55] - Free cash flow estimate for 2023 revised to $375 million, with CapEx expected to be approximately $230 million [15] Business Line Data and Key Metrics Changes - In the Metal Containers segment, adjusted EBIT increased nearly 20% from the prior year, achieving a new record for Q2 despite lower overall volumes due to prior year restocking activities [13][55] - Dispensing & Specialty Closures segment adjusted EBIT decreased by $23.4 million compared to the prior year, primarily due to skilled labor challenges and lower volume mix, particularly in Food & Beverage products in Europe [28][55] - Custom Containers segment saw a 14% decline in volumes compared to Q2 2022, resulting in a 17% decrease in sales due to non-renewal of contracts and lower food and personal care volumes [54] Market Data and Key Metrics Changes - Evidence of consumers trading down to lower-cost packaged products was noted, particularly in Europe, impacting the Food & Beverage market [9][76] - U.S. consumer demand remained resilient, with no significant impact observed from inflation, contrasting with the weaker consumer environment in Europe [76][97] Company Strategy and Development Direction - The company is shifting focus to align operational activities with revised customer inventory management initiatives for the second half of 2023, aiming to drive out costs across all business lines [7][10] - Management expressed confidence in the long-term growth outlook for the Dispensing & Specialty Closures segment, despite current challenges, and anticipates a return to growth as inventory management issues are resolved [44][98] Management's Comments on Operating Environment and Future Outlook - Management acknowledged disappointment with Q2 performance and revised outlook for the remainder of 2023, viewing current issues as transitory and expected to be resolved within the year [32][57] - The company expects adjusted net income per diluted share for 2023 to be in the range of $3.40 to $3.60, reflecting a year-over-year headwind of $0.30 per share due to interest expense [55] Other Important Information - The company wrote off tax indemnity and related tax reserves, which adversely impacted corporate expenses by approximately $2 million and interest expenses by approximately $3.5 million, while benefiting tax expenses by approximately $5 million [12] - The company is actively managing labor challenges at a U.S. Food & Beverage facility, which has resulted in significant incremental costs [23][40] Q&A Session All Questions and Answers Question: Can you elaborate on the customer inventory management programs and how they differ from previous destocking initiatives? - Management clarified that the current inventory management programs are distinct from previous COVID-related destocking, driven by significant inflation impacting both consumers and customers [16][17] Question: What are the expected benefits of restructuring programs in 2023 or 2024? - Management indicated that discussions regarding the benefits of restructuring programs would be held off until teams are fully informed of the actions being taken [34] Question: Can you provide insights on the incremental corporate development costs in the quarter? - Management stated that the costs are part of ongoing M&A activity and should not be interpreted as a change in capital allocation posture [38] Question: How confident is management that the labor issues will be resolved by the end of the year? - Management expressed confidence that the labor challenges would be resolved through various actions taken to mitigate the impact on production [40][109] Question: What is the outlook for the Dispensing & Specialty Closures segment given the current volume challenges? - Management expects low single-digit growth for the segment in the back half of the year, with confidence in long-term growth despite current challenges [43][97] Question: How does the company view the impact of inflation on consumer demand? - Management noted that while inflation is impacting consumer spending, the U.S. market remains resilient, contrasting with the weaker European market [76][95]
Silgan (SLGN) - 2023 Q1 - Quarterly Report
2023-05-03 16:59
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ________________ Commission file number 001-41459 SILGAN HOLDINGS INC. (Exact name of Registrant as specified in its charter) Delaware 06- ...
Silgan (SLGN) - 2023 Q1 - Earnings Call Transcript
2023-04-26 20:39
Silgan Holdings Inc. (NYSE:SLGN) Q1 2023 Results Conference Call April 26, 2023 11:00 AM ET Company Participants Alex Hutter - VP, IR Adam Greenlee - President, CEO Kim Ulmer - SVP, CFO & Treasurer Conference Call Participants Anthony Pettinari - Citi Arun Viswanathan - RBC Capital Markets Daniel Rizzo - Jefferies Gabe Hajde - Wells Fargo George Staphos - Bank of America Ghansham Panjabi - Baird Jeff Zekauskas - JP Morgan Kyle White - Deutsche Bank Mike Roxland - Truist Securities Operator Good day, ever ...
Silgan (SLGN) - 2022 Q4 - Annual Report
2023-02-23 16:08
(Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the transition period from to Washington, DC 20549 FORM 10-K Delaware 06-1269834 (I.R.S. Employer Identification No.) Registrant's telephone number, including area code (203) 975-7110 Securities registered pursuant to Secti ...